Arterial Filter Market Size & Share 2025 – 2034

Arterial Filter Market Size

The global arterial filter market was valued at USD 754.1 million in 2024. The market is expected to reach from USD 794.6 million in 2025 to USD 1.5 billion in 2034, growing at a CAGR of 7.1% during the forecast period. The high market growth is attributed to the increasing prevalence of cardiovascular disease, growth in cardiothoracic surgeries, technological advancements in filter design, and increasing healthcare expenditure and infrastructure, among other contributing factors.

The increasing incidence of cardiovascular diseases (CVDs), such as coronary artery disease and heart failure, increases the need for arterial filters. For instance, according to the World Health Organization (WHO), cardiovascular diseases caused 20.5 million deaths globally in 2021, accounting for 32% of deaths worldwide. The American Heart Association reported that approximately 92.1 million adults in the U.S. were suffering from some form of cardiovascular disease in 2023. These filters are essential for preventing emboli during cardiopulmonary bypass in open-heart surgeries. In addition, according to the CDC, over 375,000 open-heart surgeries were performed in the America in 2022. CVDs remain the number one cause of death globally and the need for quality surgical instruments is on the rise especially in geriatric dominated demographics.
 

Additionally, emphasis on protecting patients and following rigorous standards in surgical procedures are gaining importance. Arterial filters are instrumental in the reduction of embolic complications during extracorporeal circulation. The FDA and EMA together with other regulatory bodies support the use of such filters, which further motivates their adoption into standard practices.
 

An arterial filter is a medical device used in cardiopulmonary bypass (CPB) and extracorporeal membrane oxygenation (ECMO) circuits for the purposes of air bubble, blood clot and microemboli removal from the blood, prior to returning the blood to the patient’s arterial system. The device aids in patient safety by reducing the risk of an embolism and organ damage. These filters are essential during cardiac surgeries and other critical care procedures to ensure the blood is free from bubbles.
 

Arterial Filter Market Trends

The arterial filter industry is witnessing significant growth driven by the shift toward minimally invasive cardiac procedures, integration with advanced cardiopulmonary bypass systems, rise in customization and disposable filter solutions, and growing emphasis on biocompatible and hemocompatible materials, among other factors are boosting the industry growth.
 

• The shift towards less invasive cardiac procedures increases the demand for more compact efficient and low priming volume arterial filters. As per the Society of Thoracic Surgeons(STS) National Database, the usage of minimally invasive cardiac procedures has seen a growth of 23% from year 2021 to 2023. Moreover, the Centers for Medicare and Medicaid Services reported that hospitals adopting minimally invasive techniques for cardiac surgeries had an average patient stay of 4.5 days instead of 7 days in 2023, which translates to a 35% reduction in overall expenditure for healthcare services.
   
• There is an adoption of advanced filtration devices used by these hospitals which require specialized intraoperative filters and they have reported a decreased rate of 28 % in postoperative complications after increasing the use of perfusion filters during the same year.
   
• Further, the market for arterial filters is growing in developing countries such as India, China, and Brazil because of better access to healthcare and an increasing number of cardiac surgeries. This demand is being fueled by domestic production, government programs, and increased medical tourism. Such growth is increasing investment from global companies to form local partnerships, thereby further increasing the market.
   

Arterial Filter Market Analysis

Based on filter material, the market is segmented as polypropylene, polyethylene, polyvinyl chloride (PVC), and other filter materials. The polypropylene segment is expected to drive business growth and expand at a CAGR of 7%, reaching over USD 633.9 million by 2034.
 

• The polypropylene (PP) offers a sterile and high-stress surgical environments such as cardiopulmonary bypass is due to its remarkable resisting capabilities against chemicals and high temperatures. It undergoes no changes to its structure while being subjected to myriad temperatures of blood and sterilization for about an hour which is critical in many processes.
   
• In addition, these materials are well-known for not eliciting allergic reactions with tissues and blood and as such, do not interfere with normal body processes in biocompatibility. This is important as it is used in arterial filters which directly contacts blood. These materials help reduce thrombosis and inflammatory reactions during extracorporeal circulation. It is anticipated that these qualities will expand the growth rate of this segment of the market.
   

Based on priming volume, the arterial filter market is segmented as less than 100 mL, 100–200 mL, and more than 200 mL. The 100–200 mL segment is expected to drive business growth and expand at a CAGR of 6.9%, reaching over USD 869.2 million by 2034.
 

• The 100–200 mL arterial filters maintain an optimal balance between sufficient filtration with effective hemodilution. They are ideal for adult surgeries where there is need to preserve the patients blood volume while maintaining sufficient flow. This range minimizes the need for donor blood transfusions which is beneficial.
   
• Most adult cardiopulmonary bypass surgeries are well-matched to this priming volume range. It serves the adult’s circulatory demands without excessive extracorporeal circuit volume. The global cardiac surgery market is largely driven by adult surgical cases which ensures continual volume.
   
• Furthermore, filters 100–200 mL in volume have enhanced microbubble and air entrainment venting capabilities. This volume allows for optimal filter surface area devoid of excessive blood flow resistance. This is important for patient safety and surgical quality standards. All these factors make contributing to its market dominance.
   

Based on age group, the arterial filter market is segmented as adult and neonatal/ pediatric. The adult segment generated the highest revenue of USD 604.5 million in 2024.
 

• The increasing aging population in developed and emerging economies has led to a rise in cardiac surgeries among adults. As for the elderly demographic, the World Health Organization (WHO) stated that the population of people aged 60 years and above rose from 1 billion in 2021 to 1.4 billion in 2023. Some of the prevalent surgeries performed in this age group include CABG as well as valve replacements, which require specialized arterial filters tailored for adult circulatory systems. In U.S. alone, around 213,700 surgeries were performed in the year 2022 and there was a noted increase of about 5.2% in 2023.
   
• In addition, adult surgeries require filters with a priming volume of between 100-200 mL which is very common and well supported by perfusion equipment. These filters ensure adult patients optimal flow rate, optimal emboli capture, and protection against damaged tissues. Their standardization and reliability is one of they key reasons why they are chose in most hospitals, which in turn fuels the growth of that particular segment of the market.
   

Based on application, the arterial filter market is segmented as cardiopulmonary bypass (CPB), extracorporeal membrane oxygenation (ECMO), and other applications. The cardiopulmonary bypass (CPB) segment accounted for USD 509.4 million in market revenue in 2024 and is anticipated to grow at a CAGR of 7.3% between the 2025 to 2034 period.
 

• Arterial filters are an integral part of the CPB circuits which serve the important purpose of preventing air bubbles and microemboli from entering the patient’s arterial system after blood circulation. This is essential for protecting the patient during cardiac operations. Integration of such filters into CPB systems is commonplace, which ensures persistent demand all the time.
   
• The rise of coronary artery disease, valve defects, and congenital anomalies has caused an increase in the number of surgeries performed with CPB systems. A larger number of open-heart surgeries performed means a proportional increase in the use of arterial filters in these systems.
   
• Furthermore, filters that maintain optimal performance for removal of particulate matter, inflammatory mediators, and gaseous emboli during CPB are necessities for surgeons and perfusionists. This situation is the result of sophisticated arterial filters being developed in order to enhance surgical performance and improve patient safety through better membrane structure and decreased priming volumes.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on end use, the arterial filter market is classified into hospitals, ambulatory surgical centers, and other end users. The hospitals segment dominated the market with a revenue share of 59.1% in 2024.
 

• Hospitals are the primary centers for complex cardiac surgeries requiring cardiopulmonary bypass, where arterial filters are standard.  They have sophisticated structures and specialized cardiac units and therefore are the greatest utilizers of arterial filters. There is a correlation between surgical volumes, especially in urban hospitals, and filter demand.
   
• Moreover, the single-use arterial filter is gaining popularity due to its ease of use and efficacy in infection control, thus, are adopted more frequently to reduce infection risk. This lift in surgical throughput is particularly beneficial to infection control and hospital policies focused on patient-centered safety.
   

U.S. market accounted for USD 276.5 million in 2024. The U.S. dominated the global arterial filter market in 2023 with USD 261.9 million growing from USD 248.1 million in 2022 and is anticipated to grow at a CAGR of 7% between 2025 to 2034 period.
 

• Cardiovascular diseases are still the most prevalent cause of death in the U.S. with 928,741 deaths in 2021, as recorded by the CDC (Centers for Disease Control and Prevention). Heart disease mortality statistics 2022 indicates that approximatively 697,000 people died from heart diseases which was reported by the American Heart Association. Further, around 800,000 American citizens have a heart attack every year.
   
• In addition, the CDC estimated that 18.2 million adults had coronary artery disease, requiring over 500,000 cardiac surgeries annually in 2023.  The significant number of patients undergoing cardiovascular surgeries makes the need for arterial filters mandatory to protect patients during cardiopulmonary bypass surgeries.
   
• Moreover, the country has a highly advanced healthcare system and an equally advanced surgical infrastructure staffed with highly trained personnel. This aids in performing numerous complicated cardiac procedures which increased the demand of using arterial filters ensuring high standard surgical procedures which strengthens the country's market growth.
   

Europe arterial filter market accounted for USD 220 million in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• Numerous countries in Europe have universal healthcare that covers sophisticated surgeries, including open-heart operations. This leads to greater accessibility and utilization of government hospital and clinic services for cardiovascular care. Reimbursement policies are also favorable towards the adoption of high-standard surgical equipment.
   
• Further, the European Union’s Medical Device Regulation (MDR) imposes complianced and quality control requirements for devices like arterial filters which are border regulated. This is difficult for producers but advantageous to certified high-quality products, increasing their trust and demand on the European market.
   

U.K. arterial filter market in the Europe is projected to grow remarkably in the coming years.
 

• National Health Service (NHS) oversees the entire healthcare system of the UK, including standardized protocols for performing cardiac surgery. NHS England oversees an estimated 35,000 surgeries done in 2021-2022 which grew to 38,500 surgeries in the year 2022-2023. As reported by NHS Supply Chain, procurement volumes increased by 12% of arterial filters between 2021 and 2023 due to the serving injuries initiative post-pandemic.
   
• The NHS also enforces bulk procurement and national clinical guidelines which makes use of arterial filters during CPB procedures, further driving demand. The combination of standardization combined with high surgical volume means consistent demand for all public hospitals.
   
• The increase in obesity, diabetes as well as high blood pressure has elevated the rate of cardiovascular disease in the UK. This is contributing more toward CABG as well as replacing valves. These surgeries depend on the use of arterial filters to ensure safety during cardiopulmonary bypass (CPB).
   

The Asia Pacific arterial filter market is anticipated to grow at the highest CAGR of 8.3% during the analysis timeframe.
 

• Countries such as India, China, and those in Southeast Asia are considerably investing in healthcare infrastructure. New hospitals and cardiac centers are being built to meet the ever-growing demand of healthcare services. This growth is increasing the availability of sophisticated cardiac surgical procedures, thus elevating the demand for arterial filters in both public and private healthcare institutions.
   
• The cost-effective rates for skilled surgical professionals are drawing in patients from developed nations to Asia Pacific regions for complex cardiac procedures. This increases the demand for surgical consumables such as arterial filters. The increased influx of overseas patients to these hospitals motivates healthcare markets to ensure the provision of reliable advanced filtration devices to make them competitive in the global healthcare arena.
   

China holds a dominant position in the Asia Pacific arterial filter market.
 

• China’s private healthcare industry is booming as well, with the number of private hospitals expected to increase from 24,780 in 2021 to 27,430 by the end of 2023, as estimated by China’s National Health Commission. These hospitals offer advanced cardiac care in record time of 2-3 days compared to the 15-20 day wait time in public hospitals.
   
• Private hospitals and specialized cardiac centers use modern surgery arterial filter systems during operations to achieve better results. As reported by the Chinese Hospital Association, private healthcare facilities had increased their share of cardiac surgeries to 35% from 28% in 2021 showing how this healthcare segment is growing alongside these public institutions.
   
• Increased cardiovascular diseases in China’s urban population stems from rapid changes in lifestyle, physical inactivity, and poor eating habits. These factors are increasing the number of people needing cardiac surgery and, in turn, boost the sales of arterial filters. There is also a greater volume of surgical procedures due to early diagnosis plus the intervention programs.
   

The Brazil arterial filter market is experiencing robust growth in Latin America market.
 

• In Brazil, the increase in overweight individuals, high blood pressure, diabetes, and similar conditions is leading to more cases of cardiovascular diseases. The growing health burden is also increasing the number of surgeries performed such as coronary artery bypass grafting (CABG) and other valve surgeries which require arterial filters. There is a direct market increase due to the increasing volume of surgical cases available.
   
• Further, there are advanced cardiac care centers and improved surgical facilities being built in the urban centers, which will rectify the glaring gaps in Brazil’s healthcare system. Public and private funding is centered on upgrading out of date equipment as well as implementing modern surgical techniques. As access expands to advanced heart surgeries, this growing infrastructure is simultaneously increasing the demand for arterial filters.
   

Saudi Arabia market is poised to witness substantial growth in Middle East and Africa arterial filter market during the forecast period.
 

• Saudi Arabia’s Vision 2030 includes substantial investments in expanding and modernizing healthcare infrastructure, with a focus on advanced cardiac care facilities. New hospitals and cardiac centers are being equipped with state-of-the-art surgical technologies, increasing the demand for arterial filters used in cardiopulmonary bypass procedures.
   
• Hospitals in Saudi Arabia adopting disposable single-use arterial filters more and more to mitigate infection exposure in line with the strict infection control policies. This is backed by health accreditation bodies as well as legal frameworks that support the use of sterile, ready-to-use arterial filtration products.
   

Arterial Filter Market Share

The arterial filter industry is moderately consolidated, with the top 5 companies such as, EUROSETS, LivaNova, Medtronic, NIPRO, and TERUMO holding a combined 42% share of the global market. These leaders dominate due to their integrated cardiopulmonary product portfolios, global regulatory reach, and strong clinical reputation. The market is driven by innovation in filter efficiency, biocompatibility, and low priming volume designs. Emerging players from Asia and Latin America are gaining traction in price-sensitive regions. Competition centers around product reliability, pricing, and hospital partnerships. High regulatory and clinical validation requirements create significant barriers to entry for new entrants.
 

Arterial Filter Market Companies

Prominent players operating in the arterial filter industry include:

• Beijing MEDOS AT Biotechnology
• Braile Biomédica
• EUROSETS
• Gen World Medical Devices
• GETINGE
• Lifeline Systems
• LivaNova
• Medtronic
• NIPRO
• Pall Corporation
• SENKO Medical Instrument
• TERUMO
   
• Medtronic provides clinically proven arterial filters integrated into its comprehensive cardiopulmonary systems. Its global reputation, wide hospital network, and commitment to surgeon training reinforce its leadership in the market.
   
• TERUMO offers highly efficient arterial filters with advanced air bubble removal and low priming volumes, ensuring superior patient safety. It maintains a strong global presence and is trusted by cardiac centers for its quality and reliability in perfusion technology.
   

Arterial Filter Industry News

• In April 2022, Medtronic collaborated with GE Healthcare to enhance care delivery in Ambulatory Surgery Centers (ASCs) and Office-Based Labs (OBLs), offering a broad range of products, financial solutions, and services. This partnership supported the expansion of cardiovascular procedures in outpatient settings, boosting demand for arterial filters and related perfusion technologies.
   

The arterial filter market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Filter Material

• Polypropylene
• Polyethylene
• Polyvinyl chloride (PVC)
• Other filter materials

Market, By Priming Volume

• Less than 100 mL
• 100–200 mL
• More than 200 mL

Market, By Age Group

• Adult
• Neonatal/ pediatric

Market, By Application

• Cardiopulmonary bypass (CPB)
• Extracorporeal membrane oxygenation (ECMO)
• Other applications

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE